期刊文献+

内源性大麻素系统与神经胶质瘤细胞增殖与凋亡的关系分析 被引量:4

The relationship between endocannabinoid system and glioma cell proliferation and apoptosis
下载PDF
导出
摘要 目的:探讨细胞实验分析内源性大麻素系统与神经胶质瘤细胞增殖与调亡的关系。方法:选择鼠C6细胞和鼠U251细胞及进行培养,采用MTT法测定大麻素四氢大麻酚(THC)对C6细胞增殖的影响,采用DNA梯度电泳法检测C6细胞凋亡,采用Western Blotting法检测CB1、CB2、重组人半胱天冬酶-3(caspase-3)和过氧化物酶体增殖物激活受体(PPAR)蛋白的表达。结果:大麻素受体CB1和CB2在C6细胞和U251细胞都有表达,对比差异无统计学意义(P>0.05)。不同浓度THC(0、1、10μmol/L)的细胞生长抑制率分别为0%、6.3%、29.3%,细胞凋亡率为5.2%、7.3%和12.7%,三组间的抑制与凋亡率对比差异有统计学意义(P<0.05)。THC不同浓度组(1、10μmol/L)C6细胞中Cleaved capase-3、PPAR蛋白表达均明显升高,与空白对照组(0μmol/L)比较差异均具有统计学意义(P<0.05)。结论:内源性大麻素系统在体外能抑制鼠C6细胞的增殖和促进其凋亡,其作用的发挥与caspase-3和PPAR表达有关。 Objective:Used the cell experiments to discuss the relationship between endocannabinoid sys-tem and glioma cell proliferation and apoptosis .Methods:Selected mouse C6 cells and U251 cells were cultured , used the MTT assay to detect C6 cell proliferation by the cannabinoids THC ,used the DNA gradient gel electropho-resis assay to detect C6 cell apoptosis ,used Western Blotting assay to detect the expression of CB1 ,CB2 ,caspase-3 and the PPAR protein .Results :The CB1 and CB2 were expressed in the C6 cells and U251 cells that compared had no significant difference (P〈0 .05) .The different concentrations of THC (0 ,1 ,10 μmol /L) of cell growth in-hibition rates were 0 % ,6 .3% ,29 .3% ,and the apoptosis rate were 5 .2% ,7 .3 % and 12 .7% ,among the three groups of inhibition and apoptosis rates contrasted had significantly (P〈 0 .05) .The C6 cells Cleaved capase-3 , PPAR protein expression in the THC different concentrations (1 ,10 μmol /L)were significantly increased ,com-pared with the control group (0μmol /L) had statistically significant differences (P 〈0 .05) .Conclusion :Endoge-nous cannabinoid system in vitro can inhibit cell proliferation and promote apoptosis in mouse C 6 cells ,its role is re-lated to the caspase-3 and PPAR expression .
出处 《陕西医学杂志》 CAS 2014年第4期387-389,共3页 Shaanxi Medical Journal
关键词 神经胶质瘤 细胞凋亡 @内源性大麻素 动物 实验 大鼠 Glioma Apoptosis @Endocannabinoid Animals,laboratory Rats
  • 相关文献

参考文献12

  • 1Lu C, Shervington A. Chemoresistance in gliomas[J]. Mol Cell Biochem, 2008,312 (1-2) : 71-80. 被引量:1
  • 2Burnet NG'Lynch AG,Jefferies SJ,et a l. High grade glio- ma: imaging combined with pathological grade defines management and predicts prognosis [J]. Radiother On- col, 2007,85 (3) : 371-378. 被引量:1
  • 3Schor NF. Pharmacotherapy for adults with tumors of the central nervous system [J]. Pharmacol Ther, 2009, 121 (3) :253-264. 被引量:1
  • 4张小林,林志雄.内源性大麻素系统抗胶质瘤的作用机制[J].临床肿瘤学杂志,2011,16(3):274-277. 被引量:6
  • 5Pisanti S, Bifulco M. Endocannabinoid system modulation in cancer biology and therapy[J]. Pharmacol Res, 2009, 60(2) : 107-116. 被引量:1
  • 6Guida M,Ligresti A,De Filippis D,et al. The levels of the endocannabinoid receptor CB2 and its ligand 2-arachi- donoylglycerol are elevated in endometrial carcinoma[J]. Endocrinology, 2010,151 (3) : 921-928. 被引量:1
  • 7费帆,何永生.脑胶质瘤分子靶向与优化治疗[J].实用医院临床杂志,2011,8(2):199-201. 被引量:7
  • 8Guindon J, Hohmann AG . The endocannabinoid system and pain[J]. CNS Neurol Disord Drug Targets, 2009,8 (6) :403-105. 被引量:1
  • 9Nomura DK. Monoacylglycerol lipase regulates a fatty acid network that promotes cancer pathogenesis[J]. Cell, 2010,140(1) :49-61. 被引量:1
  • 10Fowler CJ. Targeting the endocannabinoid system for the treatment of cancer a practical view[J]. Curt Top Med Chem, 2010,10 (8) : 814-817. 被引量:1

二级参考文献59

  • 1Park DM,Rich JN.Biology of glioma cancer stem cells[J].Mol Cells,2009,28(1):7-12. 被引量:1
  • 2Lamszus K,Günther HS.Glioma stem cells as a target for treatment[J].Target Oncol,2010,5(3):211-215. 被引量:1
  • 3Aguado T,Carracedo A,Julien B,et al.Cannabinoids induce glioma stem-like cell differentiation and inhibit gliomagenesis[J].J Biol Chem,2007,282(9):6854-6862. 被引量:1
  • 4Nomura DK,Long JZ,Niessen S,et al.Monoacylglycerol lipase regulates a fatty acid network that promotes cancer pathogenesis[J].Cell,2010,140(1):49-61. 被引量:1
  • 5Thors L,Bergh A,Persson E,et al.Fatty acid amide hydrolase in prostate cancer:association with disease severity and outcome,CB1 receptor expression and regulation by IL-4[J].PLoS One,2010,5(8):12275. 被引量:1
  • 6Maccarrone M,Finazzi-Agrò A.Endocannabinoids and their actions[J].Vitam Horm,2002,65(6):225-255. 被引量:1
  • 7Velasco G,Carracedo A,Blzquez C,et al.cannabinoids and gliomas[J].Mol Neurobiol,2007,36(1):60-67. 被引量:1
  • 8Parolaro D,Massi P.Cannabinoids as potential new therapy for the treatment of gliomas[J].Expert Rev Neurother,2008,8(1):37-49. 被引量:1
  • 9Sylvester EV.Handbook of neurochemistry and molecular neurobiology:Neurotransmitter systems[M].New York:Springer US,2008:343-384. 被引量:1
  • 10Breivogel CS,Giffin G,Di Marzo V,et al.Evidence for a new G protein-coupled connabinoid receptor in mouse brain[J].Mol Pharmacol,2001,60(1):155-163. 被引量:1

共引文献10

同被引文献27

  • 1刘云,吴炎,蔡爽,赵志峰.Siewert Ⅱ型食管胃结合部癌和远端胃癌中KLK10和KLK11及KLK12表达比较研究[J].热带医学杂志,2021,21(12):1533-1538. 被引量:2
  • 2吴涛,袁先厚,江普查,文志华,吴志敏.选择性环氧合酶-2抑制剂对胶质瘤生长的影响[J].中华实验外科杂志,2004,21(12):1495-1497. 被引量:14
  • 3Kessler J,Güttler A,Wichmann H,et al.IDH1R132H mutation causes a less aggressive phenotype and radiosensitizes human malignant glioma cells independent of the oxygenation status[J].Radiother Oncol,2015,29(15):432-436. 被引量:1
  • 4Olar A,Sulman EP.Molecular markers in low-grade glioma-toward tumor reclassification[J].Semin Radiat Oncol,2015,25(3):155-163. 被引量:1
  • 5Juratli TA,Cahill DP,Mc Cutcheon IE,et al.Determining optimal treatment strategy for diffuse glioma:the emerging role of IDH mutations[J].Expert Rev Anticancer Ther,2015,15(6):603-606. 被引量:1
  • 6Ogura R,Tsukamoto Y,Natsumeda M,et al.Immunohistochemical profiles of IDH1,MGMT and P53:practical significance for prognostication of patients with diffuse gliomas[J].Neuropathology,2015,35(4):324-335. 被引量:1
  • 7Odia Y,Varma H,Tsankova NM,et al.Biphasic IDH1phenotype in a diffusely infiltrating glioma:imPLIcations for pathogenesis,treatment and prognosis[J].Clin Neuropathol,2015,34(5):282-287. 被引量:1
  • 8Izquierdo-Garcia JL,Viswanath P,Eriksson P,et al.Metabolic reprogramming in mutant IDH1 glioma cells[J].PLoS One,2015,10(2):781-782. 被引量:1
  • 9Dimitrov L,Hong CS,Yang C,et al.New developments in the pathogenesis and therapeutic targeting of the IDH1mutation in glioma[J].Int J Med Sci,2015,12(3):201-213. 被引量:1
  • 10费帆,何永生.脑胶质瘤分子靶向与优化治疗[J].实用医院临床杂志,2011,8(2):199-201. 被引量:7

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部